Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Psychiatry Neurosci. 2008 Jul;33(4):302-18.

Perinatal depression: treatment options and dilemmas.

Author information

  • 1Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and the Women's Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA. Teri_Pearlstein@brown.edu

Abstract

The treatment of depression during pregnancy and the postpartum period raises unique concerns about safety for the developing fetus and the infant. An increasing number of studies suggest adverse effects from untreated stress, anxiety and depression as well as adverse effects from antidepressant and other psychotropic medications. Even when studies suggest a lack of short-term adverse effects with some medications, the paucity of systematic longitudinal follow-up studies investigating the development of children exposed to medications during pregnancy and breastfeeding causes apprehension. This review's objective is to highlight what is currently known about the negative effects of untreated disease and exposure to psychotropic medication, the treatment dilemmas confronting women with perinatal depression and issues that future studies should address so that a woman with perinatal depression can make an optimally informed decision.

KEYWORDS:

antidepressive agents; breastfeeding; depression; postpartum period; pregnancy

PMID:
18592032
[PubMed - indexed for MEDLINE]
PMCID:
PMC2440793
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Canadian Medical Association Icon for PubMed Central
    Loading ...
    Write to the Help Desk